BSE Live
Oct 30, 16:01Prev. Close
2444.60
Open Price
2424.25
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 30, 15:56Prev. Close
2443.70
Open Price
2458.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2446.60 (47)
| Key Financial Ratios of Mankind Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 49.28 | 47.75 | 32.00 | 35.78 | 31.59 | |
| Diluted EPS (Rs.) | 49.20 | 47.68 | 32.00 | 35.78 | 31.59 | |
| Cash EPS (Rs.) | 63.50 | 58.03 | 40.52 | 40.07 | 34.96 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 347.37 | 239.04 | 190.30 | 157.68 | 121.39 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 347.37 | 239.04 | 190.30 | 157.68 | 121.39 | |
| Revenue from Operations/Share (Rs.) | 295.87 | 257.99 | 218.41 | 194.25 | 155.13 | |
| PBDIT/Share (Rs.) | 86.15 | 70.29 | 50.66 | 54.55 | 45.41 | |
| PBIT/Share (Rs.) | 71.10 | 60.35 | 42.52 | 50.39 | 42.44 | |
| PBT/Share (Rs.) | 60.69 | 59.52 | 41.41 | 48.93 | 41.94 | |
| Net Profit/Share (Rs.) | 48.45 | 48.09 | 32.38 | 35.91 | 31.99 | |
| NP After MI And SOA / Share (Rs.) | 48.25 | 47.75 | 32.00 | 35.78 | 31.59 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 29.11 | 27.24 | 23.19 | 28.08 | 29.27 | |
| PBIT Margin (%) | 24.03 | 23.39 | 19.46 | 25.94 | 27.35 | |
| PBT Margin (%) | 20.51 | 23.06 | 18.95 | 25.18 | 27.03 | |
| Net Profit Margin (%) | 16.37 | 18.64 | 14.82 | 18.48 | 20.61 | |
| NP After MI And SOA Margin (%) | 16.30 | 18.50 | 14.65 | 18.42 | 20.36 | |
| Return on Networth/Equity (%) | 13.89 | 20.43 | 17.24 | 23.28 | 26.79 | |
| Return on Capital Employed (%) | 13.27 | 24.56 | 21.69 | 30.94 | 33.87 | |
| Return on Assets (%) | 7.17 | 15.98 | 13.19 | 15.67 | 19.85 | |
| Total Debt/Equity (X) | 0.59 | 0.02 | 0.02 | 0.14 | 0.05 | |
| Asset Turnover Ratio (%) | 0.61 | 0.95 | 0.88 | 0.98 | 1.01 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.23 | 3.10 | 2.32 | 1.68 | 2.89 | |
| Quick Ratio (X) | 0.86 | 2.37 | 1.52 | 1.01 | 2.01 | |
| Inventory Turnover Ratio (X) | 6.69 | 1.21 | 0.51 | 0.64 | 0.57 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 8.28 | 83.98 | 45.63 | 37.29 | 90.29 | |
| Interest Coverage Ratios (Post Tax) (%) | 8.28 | 83.98 | 45.63 | 37.29 | 90.29 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 108,143.49 | 91,239.85 | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 8.86 | 8.83 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 30.42 | 32.40 | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 8.19 | 8.90 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 6.98 | 9.83 | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 8.19 | 8.90 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 |
13.10.2025
19.09.2025
11.09.2025
05.08.2025
01.08.2025
Mankind Pharma Consolidated June 2025 Net Sales at Rs 3,570.35 crore, up 23.4% Y-o-Y
01.08.2025
Mankind Pharma Standalone June 2025 Net Sales at Rs 2,541.36 crore, up 5.75% Y-o-Y
24.06.2025
Mankind Pharma Consolidated March 2025 Net Sales at Rs 3,079.37 crore, up 26.15% Y-o-Y
22.05.2025
Mankind Pharma Consolidated March 2025 Net Sales at Rs 3,079.37 crore, up 26.15% Y-o-Y